China Universal Asset Management Co., Ltd. Alnylam Pharmaceuticals, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

A detailed history of China Universal Asset Management Co., Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 36,340 shares of ALNY stock, worth $8.56 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

36,340

Previous 26,509 37.09%

Holding current value

$8.56 Million

Previous $6.44 Million 55.19%

% of portfolio

1.12%

Previous 0.92%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$233.81 - $287.01 $2.3 Million - $2.82 Million	9,831 Added 37.09%	36,340 $10 Million
Q2 2024 Jul 19, 2024	SELL	$143.31 - $247.0 $1.33 Million - $2.3 Million	-9,313 Reduced 26.0%	26,509 $6.44 Million
Q1 2024 Apr 29, 2024	BUY	$146.51 - $198.2 $1.42 Million - $1.92 Million	9,662 Added 36.93%	35,822 $5.35 Million
Q4 2023 May 21, 2024	SELL	$151.41 - $196.57 $1.46 Million - $1.9 Million	-9,662 Reduced 26.97%	26,160 $5.01 Million
Q4 2023 Jan 23, 2024	BUY	$151.41 - $196.57 $3.42 Million - $4.44 Million	22,580 Added 630.73%	26,160 $5.01 Million
Q3 2023 May 21, 2024	SELL	$170.77 - $211.65 $1.62 Million - $2.01 Million	-9,492 Reduced 72.61%	3,580 $634,000
Q3 2023 Oct 30, 2023	SELL	$170.77 - $211.65 $1.62 Million - $2.01 Million	-9,492 Reduced 72.61%	3,580 $634,000
Q2 2023 May 21, 2024	BUY	$185.01 - $212.05 $1.83 Million - $2.09 Million	9,868 Added 307.99%	13,072 $2.48 Million
Q2 2023 Jul 27, 2023	BUY	$185.01 - $212.05 $1.83 Million - $2.09 Million	9,868 Added 307.99%	13,072 $2.48 Million
Q1 2023 May 21, 2024	SELL	$182.66 - $235.53 $1.9 Million - $2.45 Million	-10,400 Reduced 76.45%	3,204 $641,000
Q1 2023 Apr 27, 2023	SELL	$182.66 - $235.53 $1.9 Million - $2.45 Million	-10,400 Reduced 76.45%	3,204 $642,000
Q4 2022 May 21, 2024	SELL	$185.53 - $241.31 $4.12 Million - $5.36 Million	-22,218 Reduced 62.02%	13,604 $3.23 Million
Q4 2022 Jan 31, 2023	BUY	$185.53 - $241.31 $2.32 Million - $3.01 Million	12,480 Added 1110.32%	13,604 $3.23 Million
Q3 2022 Oct 21, 2022	BUY	$138.54 - $232.0 $155,718 - $260,768	1,124 New	1,124 $225,000

Others Institutions Holding ALNY

# of Institutions

641

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account

China Universal Asset Management Co., Ltd. Alnylam Pharmaceuticals, Inc. Transaction History